Cyramza Intravenous infusion 500mg, manufactured by Eli Lilly Japan, contains Ramucirumab (genetical recombination), a monoclonal antibody that interferes with cancer cell growth. It is used to treat stomach cancer, colorectal cancer, non-small cell lung cancer, and hepatocellular carcinoma. This 500mg 50mL bottle has a YJ code of 4291429A2020.
Cyramza Intravenous infusion 500mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).